First Page | Document Content | |
---|---|---|
![]() Health Prescription Drug User Fee Act Center for Biologics Evaluation and Research Biosimilar FDA Special Protocol Assessment New Drug Application Generic drug Center for Drug Evaluation and Research Biologic Food and Drug Administration Pharmaceutical sciences Medicine | Add to Reading List |
![]() | Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmaceDocID: 1uvYN - View Document |
![]() | Emergency Use: means the use of a test article on a human subject in a life-threatening situation inDocID: 1riMu - View Document |
![]() | United States Government Accountability Office GAO Report to the Ranking Member, Committee on Finance, U.S. SenateDocID: 1riEa - View Document |
![]() | Microsoft Word - FINAL 10K2014-Cover Page final to printDocID: 1r76P - View Document |
![]() | Clark Transfer, Inc. Owner-Operator Application IMPORTANT NOTICE REGARDING BACKGROUND REPORTSDocID: 1qZGZ - View Document |